With a simple message a single-loop animation, this banner ad successfully delivers the approval message to neurologists.
Ocrevus Now Approved Banner Ads on MedPageToday
Brand: Ocrevus (ocrelizumab), Intravenous Infusion
Parent Company: Genentech
Drug Type: Prescription
Drug Category: Neurology
Campaign: now-approved
Targeting: HCPs
Patient Website: https://www.ocrevus.com/patient.html
HCP Website: https://www.ocrevus.com/hcp.html